Epidemiology of patellar tendinopathy in elite male soccer players
Hägglund M, Zwerver J, Ekstrand J
The American journal of sports medicine · 82 citations
Review labels
Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.
How it was studied
- Design
- Cohort study (indexed by PubMed)
- Studied in
- People
- Main outcome
- Clinical events such as disease or death
Who paid for it
- Funding
- Funding not disclosed
Publication
- Published
- 2011-06-03 · Am J Sports Med · vol. 39 · issue 9 · pp. 1906–1911
- Publisher
- SAGE Publishing
- Cited
- 138 citations · more than 93% of similar papers · 3.6× the field average
- Impact
- Top 10% most cited in its field
- References
- 31 works
- Access
- Open access (repository copy) · OTHER-OA
- Research areas
- Tendon Structure and Treatment · Sports injuries and prevention · Lower Extremity Biomechanics and Pathologies
- Keywords
- Medicine, Epidemiology, Tendinopathy, Cohort, Cohort study, Logistic regression, Odds ratio, Confidence interval, Physical therapy, Incidence (geometry), Rate ratio, Athletes, Surgery, Tendon, Internal medicine
- MeSH
- patellar ligament, humans, knee injuries, incidence, prevalence, risk factors, cohort studies, european union, soccer, adult, male, tendinopathy, young adult
3 authors
From SE, NL
- Martin Hägglund · correspondingLinköping University
- Johannes ZwerverUniversity Medical Center Groningen; University of Groningen
- Jan EkstrandLinköping University
Abstract
Background
Patellar tendinopathy is common among athletes in jumping sports and in sports with prolonged repetitive stress of the knee extensor apparatus. The epidemiology in soccer is not well described.
Purpose
This study was undertaken to investigate and describe the epidemiology of patellar tendinopathy in elite male soccer players and evaluate potential risk factors.
Study design
Cohort study; Level of evidence, 2.
Methods
Between 2001 and 2009, the authors followed 51 European elite soccer clubs (2229 players) from 3 different cohorts: the Swedish First League cohort (SWE) and Union of European Football Associations (UEFA) Champions League cohort (UCL), both playing on natural grass; and the Artifical Turf cohort (ART), playing on third-generation artificial turf. Individual player exposure in training and matches and time-loss injuries were recorded.
Results
In total, 137 patellar tendinopathies were recorded, comprising 1.5% of all injuries and corresponding to an incidence of 0.12 injuries/1000 hours. Each season, 2.4% of players were affected, with most injuries (61%) resulting in absence up to 1 week or less. Twenty percent of tendinopathies were recurrent complaints. No significant difference in season prevalence (odds ratio [OR], 0.93; 95% confidence interval [CI], 0.60-1.44; P = .74) or incidence (rate ratio [RR] 1.20; 95% CI, 0.82-1.75; P = .36) was observed between teams playing on artificial turf and natural grass, respectively. Multivariate logistic regression showed that a high total exposure hours (OR, 1.02 per 10-hour increase; 95% CI, 1.00-1.04; P = .033) was a significant risk factor for patellar tendinopathy, and increased body mass was borderline significant (OR, 1.15 per 5-kg increase; 95% CI, 1.00-1.33; P = .055). In addition, 2 acute partial tendon ruptures were recorded, but no total rupture.
Conclusion
Although mainly mild in nature, patellar tendinopathy is a fairly common condition in elite soccer and the recurrence rate is high. Exposure to artificial turf did not increase the prevalence or incidence of injury. High total amount of exposure was identified as a risk factor for patellar tendinopathy.
Abstract via Europe PMC. Copyright remains with the authors or publisher.
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.